The clinical drug candidate anle138b binds in a cavity of lipidic α-synuclein fibrils

Bibliographic Details
Title: The clinical drug candidate anle138b binds in a cavity of lipidic α-synuclein fibrils
Authors: Leif Antonschmidt, Dirk Matthes, Rıza Dervişoğlu, Benedikt Frieg, Christian Dienemann, Andrei Leonov, Evgeny Nimerovsky, Vrinda Sant, Sergey Ryazanov, Armin Giese, Gunnar F. Schröder, Stefan Becker, Bert L. de Groot, Christian Griesinger, Loren B. Andreas
Source: Nature Communications, Vol 13, Iss 1, Pp 1-10 (2022)
Publisher Information: Nature Portfolio, 2022.
Publication Year: 2022
Collection: LCC:Science
Subject Terms: Science
More Details: Understanding how small molecules bind to pathological aggregates is of importance for therapeutic and diagnostic development in diseases such as Parkinson’s Disease. Here, the authors reveal a binding site of anle138b to lipid-induced α-synuclein fibrils.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2041-1723
Relation: https://doaj.org/toc/2041-1723
DOI: 10.1038/s41467-022-32797-w
Access URL: https://doaj.org/article/ed3eab20b6124a5585faf679ec466929
Accession Number: edsdoj.3eab20b6124a5585faf679ec466929
Database: Directory of Open Access Journals
More Details
ISSN:20411723
DOI:10.1038/s41467-022-32797-w
Published in:Nature Communications
Language:English